Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for DAPAGLIFLOZIN

Ingredient

DAPAGLIFLOZIN

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
AURO-DAPAGLIFLOZIN / METFORMIN	850MG 5MG	TABLET	Resolved	2024-11-14	2025-01-29	242954
GLN-DAPAGLIFLOZIN	5MG	TABLET	Actual shortage	2025-12-09	2025-12-10	273856
PMS-DAPAGLIFLOZIN	5MG	TABLET	Resolved	2025-01-17	2025-02-21	248000
PRO-DAPAGLIFLOZIN	10MG	TABLET	Resolved	2024-04-12	2024-04-25	224975
SANDOZ DAPAGLIFLOZIN	10MG	TABLET	Resolved	2025-05-05	2025-05-27	256661
SANDOZ DAPAGLIFLOZIN	10MG	TABLET	Resolved	2024-07-02	2024-08-13	231744
SANDOZ DAPAGLIFLOZIN	10MG	TABLET	Resolved	2024-03-05	2024-05-14	221380
SANDOZ DAPAGLIFLOZIN	10MG	TABLET	Resolved	2024-01-16	2024-02-06	216168
SANDOZ DAPAGLIFLOZIN	10MG	TABLET	Resolved	2023-11-20	2024-01-17	210838
SANDOZ DAPAGLIFLOZIN	10MG	TABLET	Resolved	2023-09-05	2023-10-17	203653

Showing 11 to 20 of 24

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports

1

Showing 1 to 0 of 0